Caption Management, LLC Bridge Bio Pharma, Inc. Transaction History
Caption Management, LLC
- $8.03 Billion
- Q2 2025
A detailed history of Caption Management, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Caption Management, LLC holds 130,000 shares of BBIO stock, worth $8.24 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
130,000
Previous 246,500
47.26%
Holding current value
$8.24 Million
Previous $8.52 Million
34.13%
% of portfolio
0.07%
Previous 0.09%
Shares
8 transactions
Others Institutions Holding BBIO
# of Institutions
412Shares Held
187MCall Options Held
11.3MPut Options Held
1.93M-
Viking Global Investors LP18.6MShares$1.18 Billion2.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.5MShares$1.04 Billion0.01% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY13.3MShares$840 Million22.63% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$789 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X09.28MShares$588 Million0.21% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $9.39B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...